Outcomes4Me Secures $21M in Funding Learn more >>

Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard
Login
Sign up
Log out
Open the app
/ Press

Get to know us better and help spread the word.

Our purpose is to improve outcomes for everyone by empowering cancer patients and democratizing healthcare. Please contact us with any press requests or inquiries.

PR@outcomes4me.com

Featured Coverage

Outcomes4Me treatment plan

Outcomes4Me named to TIME’s list of the Best Inventions of 2025

After experiencing a cancer scare, former Novartis executive Maya R. Said saw firsthand how nebulous...
:: TIME
MM+M logo

Outcomes4Me partners with Labcorp and NBCUniversal on cancer care

While it’s impossible to quantify the impact of medical innovation on the world of cancer...
:: MM+M

Health Tech: Maya Said On How Outcomes4Me’s Technology Can Make An Important Impact On Our Overall Wellness

You need to be very, very clear on the compass of your company. What value...
:: Medium

In the News

Pfizer's Science Will Win podcast logo
:: Pfizer’s Science Will Win Podcast

The Pace of Science: AI in Cancer Care

Outcomes4Me Founder and CEO Maya Said is featured on the Pfizer Science Will Win podcast.
Miami Breast Cancer Conference logo
:: ONCOLOGY

Real-World Biomarker Testing in HR+/HER2- Metastatic Breast Cancer

Outcomes4Me’s research study featured as a poster session at the Miami Breast Conference now published...
Inc. Regionals 2026
:: Inc.

Outcomes4Me is #13 on the 2026 Inc. Regionals list

Outcomes4Me is #13 on the 2026 Inc. Regionals list
AI imagery and text over an image of a woman holding a phone
:: Cancer Today

A Digital Ally

Outcomes4Me Founder and CEO Maya Said speaks with Cancer Today about AI tools in cancer...
Inc. Female Founders 500
:: Inc. Magazine

Maya Said named to 2026 Inc. Female Founders 500

Outcomes4Me Founder and CEO Maya Said named to the 2026 Inc. Female Founders 500
Frontiers in Digital Health logo
:: Frontiers in Digital Health

Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer

Outcomes4Me and Labcorp collaborated on a research study, featured in Frontiers.
Suzanne Garner and family
:: After Treatment

Finding the Clinical Trial That Can Extend Your Life

Suzanne Garner isn’t cured. She’s also not acutely sick. She lives in the same grey...
Outcomes4Me treatment plan
:: TIME

Outcomes4Me named to TIME’s list of the Best Inventions of 2025

After experiencing a cancer scare, former Novartis executive Maya R. Said saw firsthand how nebulous...

Press Releases

Outcomes4Me Named to TIME’s List of The Best Inventions of 2025

BOSTON–OCTOBER 9, 2025 –Today, Outcomes4Me announced it has been named to TIME’s Best Inventions of...

Outcomes4Me Acquires Germany’s Mika Health App to Accelerate AI-Driven Patient Empowerment Globally

Mika’s cancer app is a certified medical device clinically proven to help cancer patients cope...

Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care

BOSTON–May 29, 2025– Outcomes4Me Inc., the developer of the leading direct-to-patient, AI-driven platform transforming the...

Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment

UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader...

If you’re a member of the press,
please reach out.

PR@outcomes4me.com